Headlines
DNA Down Under
New section on RNA interference as a tool to block virus replication.
|
Cytochemistry
and Immunochemistry
-
Stains
used in the differentiation and classification of acute leukaemias
(AL) according to the FAB system.
-
Myeloperoxidase (MPO) is found in azurophilic granules ie.
in the immature granulocytic series (>3% of blasts should
be positive for the myeloid group, and <3% for the lymphoid
group)
-
These do not cause alteration of the cellular morphology
-
These criteria refer to the immature cells only
-
Muramidase is released by monocytes
-
TdT catalyses the addition of dinucleoside triphosphate onto
the free end of ssDNA without a template
- Not
in normal, mature lymphocytes but is present in 65% of
the total thymic population of lymphocytes
- 1-3%
of all normal BM cells are POS
- T-ALL
are TdT POS but B-ALL are NEG
| Leukaemia |
Assay |
| Myeloperoxidase
or Sudan Black B |
Esterases |
PAS
Periodic acid-Schiff |
Muramidase
"Lysozyme" |
TdT
Terminal deoxynucleotidyl transferase |
Specific
a-Naphthol AS-D chloroacetate esterase |
Non-Specific
a-Naphthyl
acetate esterase & a-naphthyl butyrate esterase |
| AML-M1 |
+ |
++
- |
- |
+
- |
- |
-
or + |
| AML-M2 |
+
+++ |
++ |
- |
+
- |
+/- |
- |
| AML-M3 |
+++ |
+++ |
- |
+
- |
++ |
- |
| AML-M4 |
++
+++ |
+
+++ |
+
+++ |
+
- |
++ |
- |
| AML-M5 |
+ |
- |
+++ |
+
- |
+++ |
- |
| AML-M6 |
- |
- |
- |
+++ |
- |
- |
| AML-M7 |
- |
-
++ |
-
++ |
++ |
- |
- |
| ALL |
- |
- |
-
(+ for CLL & T-ALL) |
+++ |
- |
+++ |
| Normal
Neutrophils |
+++ |
+++ |
- |
+++ |
- |
- |
| Normal
Monocytes |
+ |
- |
+++ |
+++ |
+++ |
- |
| Normal
Lymphocytes |
- |
- |
- |
+/- |
- |
- |
| Platelets |
|
|
+
(a-Naphthyl a-e eg. Megakaryocytes), - (a-Naphthyl
b-e eg. M7) |
+++ |
|
|
Myeloperoxidase
(MPO)
- A lysosomal
enzyme localised to the azurophilic granules of neutrophils
and monocytes. Can be demonstrated in eosinophils and basophils.
- Completed
in minutes
- Fixation
in glutaraldehyde in PBS, rinsed and immersed substrate
in Tris-HCl + H2O2, rinsed again and
placed in enhancing solution. To clarify detail, the cells
are counter-stained with Giemsa
- Substrates
include:
.o-toluidine
.3,3'-diaminobenzidine (DAB)
.2,7-fluorenediamine (FDA)
.3-amino-9-ethylcarbazole
- Only
really of value if POS, immature cells. NEG
can result in M0, M7 (monoblasts) and ALL (lymphocytes and
lymphoblasts)
- Developing
granulocytes are always POS. Strongly in promyelocytes and
myelocytes but may be NEG in early myeloblasts. Almost all
mature neutrophils give POS reactions as do eosinophils,
basophils, promonocytes and monocytes.
- Main
function of this test is in the distinction between AML
and ALL
Sudan
Black B
Chloro-acetate
esterase (CAE)
- A specific
esterase (capable of liberating naphthol from a naphthol
AS-D chloroacetate substrate) present in granulocytes and
mast cells distinct from that in monocytes and megakaryocytes
- Auer
rods are POS
- Optimal
pH of 7.0-7.6
- Not inhibited
by sodium fluoride (NaF)
- Enzyme
activity can be seen in paraffin embedded sections
- Can use
fast garnet, fast red violet or fast blue
as chromogens in the reaction
Non-specific
esterases
- POS for
the monocytic series
Periodic
Acid Schiff's (PAS) Stain
- looking
for abnormal amounts of glycogen, glycoproteins, mucoproteins
and high molecular weight carbohydrates
- Schiff's
reagent reacts with aldehydes formed by periodic acid breaking
down (oxidising) the C-C bond in CHOH-CHOH groups
- Most
cells POS but intensity and pattern varies
- Another
way of typing the variants is called immunophenotyping
- Monoclonal
antibodies toward cell-type restricted antigens are used in
this highly specific method
| Antigens |
Cluster
of Differentiation (CD) Number |
FAB
Nomenclature |
| M1 |
M2 |
M3 |
M4 |
M5 |
M6 |
M7 |
| HLA-DR |
|
+ |
+ |
- |
+ |
+/- |
+/- |
+/- |
| MY9,
LF3 |
CD33 |
+ |
+ |
+ |
+ |
+/- |
+/- |
+/- |
| MCS-2,
MY7 |
CD13 |
+ |
+ |
+ |
+ |
+ |
- |
|
| Mo1,
OKM1 |
CD11b |
- |
+ |
+/- |
+ |
+ |
- |
|
| LeuM1 |
CD15 |
- |
+ |
+/- |
+ |
+ |
+/- |
|
| Mo2,
UCHM1 |
CD14 |
- |
- |
- |
+ |
+ |
- |
|
| Glycophorin
A |
|
- |
- |
- |
- |
- |
+ |
- |
| Glycoprotein
IIb/IIIa |
CDw41 |
- |
- |
- |
- |
- |
- |
+ |
| Glycoprotein
Ib |
CDw42 |
- |
- |
- |
- |
- |
- |
+ |
| von
Willebrand factor (vWF) |
- |
- |
- |
- |
- |
- |
- |
+ |
New
look for June 2003
|